Back to search results

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Abroad (travel likely)Recruiting

Conditions

Obesity · Liver Diseases · Liver Fibrosis · Liver Fat · Metabolic Dysfunction-Associated Steatotic Liver Disease · Metabolic Dysfunction-Associated Steatohepatitis · MASLD · MASH · Weight Loss · Insulin Resistance · Insulin Sensitivity · Insulin Sensitivity/Resistance · Metabolic Disease · Diabetes · Diabetes Mellitus, Type 2 · NASH With Fibrosis · Non-Alcoholic Fatty Liver Disease · Non Alcoholic Fatty Liver · Non-alcoholic Steatohepatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Michele B. Ryan, MS) · mryan@bwh.harvard.edu · 617-525-8266
    Contact: Principal Investigator (Pichamol Jirapinyo, MD, MPH)

  • West Virginia University, Morgantown, West Virginia, United States

    Contact: Study coordinator (Soban Researcher) · muhammadsobanarif.maan@hsc.wvu.edu · 304-293-4946
    Contact: Principal Investigator (Shailendra Singh, MD)
Study leads

  • Pichamol Jirapinyo, MD, MPH

    Principal Investigator

    Brigham and Women's Hospital

View source on ClinicalTrials.gov(opens in a new tab)